The Assessment of Knowledge in Sample of Iraqi Patients with Ankylosing Spondylitis


Ankylosing spondylitis
chronic inflammatory disease
musculoskeletal symptoms

How to Cite

Jassim, N., & Majeed, S. (2020). The Assessment of Knowledge in Sample of Iraqi Patients with Ankylosing Spondylitis. Rheumatology (Bulgaria), 28(1), 31-40.


Ankylosing spondylitis (AS) is a chronic inflammatory disease of the sacroiliac joints and spine that may be associated with a variety of extra-spinal lesions. Knowledge acquisition is a complex procedure and depends on patient intelligence, level of education, motivation teaching style and content. Different models have been identified to increase level of knowledge, with educational courses and information booklets among the most common. The aim of the present study is to assess a level of knowledge in sample of Iraqi patients with ankylosing spondylitis, by a self-administered questionnaire. This is a cross-sectional study including 200 Iraqi patients with AS, who have access to the Rheumatology Unit in Baghdad Teaching Hospital. AS Data collection were taking place between November 2017 and September 2018. Socio demographic data were reported including age, residence, marital status, smoking, educational level, occupation and disease diagnosis duration. Patients had undergone an interview with a physician to assess their level of knowledge by a questionnaire, which included 4 knowledge areas: Area A includes general knowledge about AS, comprising etiology, symptoms musculoskeletal and extra musculoskeletal, and laboratory blood tests. Area B includes immuno-genetics test (HLA.B27 antigen) and inheritance. Area C includes general management, including pharmacological treatment and its side effects, physical therapy and exercise (exercise type & proper duration and its role in treatment). Area D includes joints protection, pacing and priorities. The clinical and demographic data analyzed using descriptive statistics. The mean total questionnaire score is 16.28 SD +- 2.49, range (2 – 26). There is no significant statistical association between the mean total score and the gender (P value = 0.14), age (P value 0.93), marital status (P value 0.73), smoking (P value 0.65), residence (P value 0.56), and BMI (P value 0.23), While there is a highly significant statistical relationship between mean total score and the level of education (P value 0.0004), and occupation (P value 0.0026). For Area A, the mean achieved score is 3.63 +- SD 1.61, maximum possible score is 8. For Area B, the mean achieved score is 0.26 +-SD 0.51, the maximum possible score is 2. For Area C, the mean achieved score is 9.53 +- SD 2.42, maximum possible score is 15. Area D, the mean achieved score is 2.87 +- SD 1.06, the maximum possible score is 4. The study showed that AS Iraqi patients have low level of knowledge, unawareness and wrong thoughts about specific aspects of their disease, which may reinforce the recommendation of this study.


  1. Hamilton L, Barkham N, Bhalla A, et al. BSR and BHPR guideline for the treatment of axial spondyloarthritis (including ankylosing spondylitis) with biologics. J Rheumatol. 2016;56(2):313-6.
  2. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum. 2005 Apr;52(4):1000-8.
  3. Van der Linden SM, Valkenburg HA, de Jongh BM, et al: The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum. 27:241–249, 1984.
  4. Li Z, Brown MA. Progress of genome‐wide association studies of ankylosing spondylitis.CTI. 2017;6(12).
  5. Nasution AR, Marjuadi A, Kunmartini S, et al. HLA-B27 subtypes positively and negatively associated with spondylarthropathy. J Rheumatol. 24:1111–1114, 1997.
  6. López‐Larrea C, Sujirachato K, Gonzalez‐Roces S, et al. HLA‐B27 subtypes in Asian patients with ankylosing spondylitis. Evidence for new associations. HLA. 1995;45(3):169-76.
  7. Khan MA. Update on spondyloarthropathies. Ann Intern Med. 2002;136(12):896-907.
  8. Jaakkola E, Herzberg I, Laiho K, et al. Finnish HLA studies confirm the increased risk conferred by HLA B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis .2006;5(6):775-80.
  9. Al-Bedri KZ. Prevalence, Clinical Features, and Radiological Features of Iraqi Patients with Ankylosing Spondylitis. JNSR. 2014;4(24).
  10. AL-RAWI ZS, Al-Shakarchi HA, Hasan F, et al. Ankylosing spondylitis and its association with the histocompatibility antigen HL-A B27: an epidemiological and clinical study. J Rheumatol. 1978;17(2):72-5.
  11. François RJ, Neure L, Sieper J, et al. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases. Ann Rheum Dis. 2006;65(6):713-20.
  12. Layh-Schmitt G, Colbert RA. The IL-23/IL-17 Axis in Spondyloarthritis. Curr Opin Rheumatol. 2008;20(4):392.
  13. Ebringer A. The relationship between Klebsiella infection and ankylosing spondylitis. Bailliere Clin Rheumatol. 1989;3(2):321-38.
  14. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;68(Suppl 2):ii1-44.
  15. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-5.
  16. Machado PM, Landewé R, van der Heijde D. Assessment of SpondyloArthritis international Society (ASAS) Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018;77:1539-1540.
  17. Van der Heijde D, Sieper J, Maksymowych WP, et al. Assessment of SpondyloArthritis international Society. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum Dis. 2011;70(6):905-8.
  18. Thompson B. Education and learning for people with Ankylosing Spondylitis. MD theisis, Newcastle University, 2011. 59. Maggs FM, Jubb RW, Kemm JR. Single-blind randomized controlled trial of an educational booklet for patients with chronic arthritis. Rheumatol. 1996;35(8):775-7.
  19. Mahmud T, Comer M, Roberts K et al. Clinical implication of patients’ knowledge. CJR. 1995;14:627–30.
  20. Helliwell PS, O'Hara M, Holdsworth J, et al. A 12-month randomized controlled trial of patient education on radiographic changes and quality of life in early rheumathoid arthritis. Rheumatol. 1999;38:303-8.
  21. Salman S, SAlnuaimi A, Lateef NA, et al. Assessment of Knowledge and Attitude in a Sample of Patients with Rheumatoid Arthritis and Its Association with Disease Activity and Severity: A Cross-Sectional Study. OJRA. 2014;4(04):226.
  22. Kona Kaut I, Ezzhara abourazzak F, Jamila E, et al. Axial Spondyloarthritis and Cigarette Smoking. The Open Rheumatology Journal. 2017, 11, 53-61.
  23. Jennings F, Toffolo S, De Assis MR, et al. Brazil Patient Knowledge Questionnaire (PKQ) and evaluation of disease-specific knowledge in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology. 2006;24(5):521-8.
  24. Suda AL, Jennings F, Bueno VC, et al. Development and validation of fibromyalgia knowledge questionnaire: Fkq. Rheumatology international.2012;32(3):655-62.
  25. Ribeiro LH, Jennings F, Jones A, et al. Effectiveness of a back school program in low back pain. Clinical and Experimental Rheumatology. 2008;26(1):81.
  26. Tarimo N, Diener I. Knowledge, attitudes and beliefs on contributing factors among low back pain patients attending outpatient physiotherapy treatment in Malawi. South African Journal of Physiotherapy. 2017;73(1):8-pages.
  27. Lubrano E, Helliwell P, Moreno P, et al. The assessment of knowledge in ankylosing spondylitis patients by a self-administered questionnaire. Rheumatology (Oxford, England). British journal of rheumatology. 1998;37(4):437-41.
  28. Van der Heijde D, Dougados M, Davis J, et al. ASsessment in Ankylosing Spondylitis International Working Group/Spondylitis Association of America recommendations for conducting clinical trials in ankylosing spondylitis. Arthritis Rheum. 2005;52(2):386-94.
  29. Van der Heijde D, Ramiro S, Landewé R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017.
  30. Claudepierre P, Flipo RM, Sibilia J, et al. Patient knowledge of their disease: a French multicenter study in ankylosing spondylitis. Joint bone spine. 2004;71(6):550-6.
  31. Orlandi A, Brumini C, Jones A, et al. Translation to Brazilian Portuguese, cultural adaptation and reproducibility of the questionnaire" Ankylosing Spondylitis: What do you know?". Sao Paulo Med J. 2016;134(5):407-16.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Download data is not yet available.